$599
BD Swatch pump 510(k) withdrawn; BD CY Q2 ’19 (FY Q3 ’19) Earnings Update
BD hosted their CY Q2 ’19 (FY Q3 ’19) earnings call (press release) and provided a brief update on their diabetes business unit including the 510(k) withdrawal of their Swatch pump for T2DM. Below, FENIX provides further details on the Swatch pump 510(k) withdrawal and insight into its impact on the T2DM patch pump segment.